Humana Inc. (HUM) vs Pfizer Inc. (PFE)
PFE leads on 13 of 16 compared metrics.
A side-by-side comparison of Humana Inc. and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — HUM vs PFE
growth of $100 · last 30yHUM +1941.1%PFE +119.4%HUM compounded faster
Log scale — wide-divergence pair
HUM PFE
HUM vs PFE: by the numbers
- •PFE is the larger company ($148.19B vs $45.65B market cap).
- •PFE trades at the lower earnings multiple (19.85 vs 40.67 P/E).
- •PFE converts more revenue to profit (11.83% vs 0.82% net margin).
- •HUM grew revenue faster over the past five years (11.71% vs 8.22% CAGR).
- •PFE pays the higher dividend yield (6.62% vs 0.93%).
Which is better, HUM or PFE?
Metric tally: HUM 3 · PFE 13It depends on what you're optimizing for:
ValuePFE(lower P/E)
GrowthHUM(faster 5Y revenue CAGR)
IncomePFE(higher dividend yield)
QualityPFE(higher ROIC)
Metrics side by side
Valuation
| Metric | HUM | PFE |
|---|---|---|
| P/E ratio | 40.67 | 19.85● |
| Forward P/E | 24.00 | 9.21● |
| P/S ratio | 0.33● | 2.35 |
| P/B ratio | 2.47 | 1.65● |
| EV / EBITDA | 19.26 | 12.64● |
| FCF yield | 2.77% | 6.37%● |
Profitability
| Metric | HUM | PFE |
|---|---|---|
| Gross margin | 14.01% | 69.35%● |
| Operating margin | 1.01% | 23.45%● |
| Net margin | 0.82% | 11.83%● |
| ROE | 6.08% | 8.31%● |
| ROIC | 3.12% | 8.84%● |
Dividends
| Metric | HUM | PFE |
|---|---|---|
| Dividend yield | 0.93% | 6.62%● |
| Payout ratio | 35.87% | 126.47% |
Growth (annualized)
| Metric | HUM | PFE |
|---|---|---|
| Revenue CAGR (5Y) | 11.71%● | 8.22% |
| EPS CAGR (5Y) | -17.27% | -3.78%● |
| FCF CAGR (5Y) | -17.19% | -3.79%● |
| Total return CAGR (5Y) | -1.22%● | -3.21% |
Frequently asked
- Which is better, HUM or PFE?
- It depends on your goal. value: PFE (lower P/E); growth: HUM (faster 5Y revenue CAGR); income: PFE (higher dividend yield); quality: PFE (higher ROIC). Across all compared metrics, PFE leads 13 to 3.
- Is HUM or PFE cheaper?
- On trailing earnings, PFE is cheaper: HUM trades at a 40.67 P/E and PFE at 19.85.
- Which has grown faster, HUM or PFE?
- Over the past five years, HUM grew revenue faster — HUM at a 11.71% CAGR versus PFE at 8.22%.
- Does HUM or PFE pay a bigger dividend?
- HUM yields 0.93% and PFE yields 6.62% based on trailing dividends and the latest price.
- Is HUM or PFE more profitable?
- PFE runs the higher net margin — HUM at 0.82% versus PFE at 11.83%.
- Which has been the better investment, HUM or PFE?
- Over the past 10-year, HUM delivered the higher annualized total return — HUM at 8.34% versus PFE at 2.20%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Humana P/E ratioPfizer P/E ratioHumana dividend yieldPfizer dividend yieldHumana ROEPfizer ROEHumana operating marginPfizer operating marginHumana revenue growthPfizer revenue growthHumana free cash flowPfizer free cash flow
Humana & Pfizer appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.